OncoVista Innovative Therapies Inc
OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatmen… Read more
OncoVista Innovative Therapies Inc (OVIT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2015: 0.004x
Based on the latest financial reports, OncoVista Innovative Therapies Inc (OVIT) has a cash flow conversion efficiency ratio of 0.004x as of September 2015.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-26.80K) by net assets ($-6.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
OncoVista Innovative Therapies Inc - Cash Flow Conversion Efficiency Trend (2004–2014)
This chart illustrates how OncoVista Innovative Therapies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
OncoVista Innovative Therapies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OncoVista Innovative Therapies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Everlert Inc
PINK:EVLI
|
0.000x |
|
Green Mountain Devel
PINK:GMND
|
0.082x |
|
Bourque Indts Inc
PINK:BORK
|
-0.088x |
|
Crumbs Bake Shop Inc
PINK:CRMBQ
|
1.190x |
|
GeckoSystems International Corp
PINK:GOSY
|
-0.203x |
|
Resgreen Group International Inc
PINK:RGGI
|
0.079x |
|
Health-Chem Corporation
PINK:HCLC
|
0.011x |
|
Technology Solutions Co
PINK:TSCC
|
-0.113x |
Annual Cash Flow Conversion Efficiency for OncoVista Innovative Therapies Inc (2004–2014)
The table below shows the annual cash flow conversion efficiency of OncoVista Innovative Therapies Inc from 2004 to 2014.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2014-12-31 | $-5.66 Million | $-232.38K | 0.041x | -72.57% |
| 2013-12-31 | $-3.12 Million | $-466.79K | 0.150x | -83.83% |
| 2012-12-31 | $-1.68 Million | $-1.55 Million | 0.925x | -92.87% |
| 2011-12-31 | $-124.03K | $-1.61 Million | 12.972x | +3971.70% |
| 2010-12-31 | $1.66 Million | $-554.96K | -0.335x | -513.60% |
| 2009-12-31 | $-11.25 Million | $-911.24K | 0.081x | -82.49% |
| 2008-12-31 | $-8.35 Million | $-3.86 Million | 0.463x | -35.85% |
| 2007-12-31 | $-3.99 Million | $-2.88 Million | 0.721x | +872.73% |
| 2005-12-31 | $-1.57 Million | $-116.71K | 0.074x | -41.22% |
| 2004-12-31 | $-1.30 Million | $-164.05K | 0.126x | -- |